Acute myeloid leukaemia (AML) accounts for approximately 80% of acute leukaemia diagnosed in adults and the 5-year overall AML survival rate is 15%. Mutational status of FMS-like tyrosine kinase 3 (FLT3) is now well recognised as delineating a subty...